Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 12;9(6):60.
doi: 10.3390/bs9060060.

Speech-Stimulating Substances in Autism Spectrum Disorders

María Andrea Castillo  1 , Kendy Eduardo Urdaneta  2   3 , Neomar Semprún-Hernández  4   5 , Anna Lisa Brigida  6 , Nicola Antonucci  7 , Stephen Schultz  8 , Dario Siniscalco  9   10
Affiliations
Review

Speech-Stimulating Substances in Autism Spectrum Disorders

María Andrea Castillo et al. Behav Sci (Basel). .

Abstract

Autism spectrum disorder (ASD) is characterized by the core domains of persistent deficits in social communication and restricted-repetitive patterns of behaviors, interests, or activities. A heterogeneous and complex set of neurodevelopmental conditions are grouped in the spectrum. Pro-inflammatory events and immune system dysfunctions are cellular and molecular events associated with ASD. Several conditions co-occur with ASD: seizures, gastro-intestinal problems, attention deficit, anxiety and depression, and sleep problems. However, language and speech issues are key components of ASD symptoms current therapies find difficult to face. Several speech-stimulating substances have been shown to be effective in increasing speech ability in ASD subjects. The need for large clinical trials to determine safety and efficacy is recommended.

Keywords: autism spectrum disorder; language; nutrition; speech.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Key elements of cognitive process regulation through substances discussed in the manuscript and their chemical structures.
See this image and copyright information in PMC

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association; Washington, DC, USA: 1994. (DSM-IV)
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Washington, DC, USA: 2013. (DSM-V)
    1. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 2012;26:383–392. doi: 10.1016/j.bbi.2011.08.007. - DOI - PMC - PubMed
    1. Xu N., Li X., Zhong Y. Inflammatory cytokines: Potential biomarkers of immunologic dysfunction in autism spectrum disorders. Med. Inflamm. 2015;2015:531518. doi: 10.1155/2015/531518. - DOI - PMC - PubMed
    1. Siniscalco D., Schultz S., Brigida A.L., Antonucci N. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders. Pharmaceuticals (Basel) 2018;11:56. doi: 10.3390/ph11020056. - DOI - PMC - PubMed

LinkOut - more resources